Prostaglandins A and J arrest the cell cycle of cultured vascular smooth muscle cells without suppression of c-myc expression

Toshiyuki Sasaguri, Junichi Masuda, Kentaro Shimokado, Tasuku Yokota, Chiya Kosaka, Masatoshi Fujishima, Jun Ogata

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

The effects of prostaglandins (PGs) A and J, which are antitumor eicosanoids, on the proliferation of cultured vascular smooth muscle cells were investigated. Serum-stimulated DNA synthesis was potently inhibited by PGA1, PGA2, PGJ2, and δ12-PGJ2 in similar dose-dependent fashions. The effects of PGA1 and PGA2 were reversible when they were removed from the culture media, whereas recoveries were only partial in the cells treated with PGJ2 and δ12-PGJ2. PGs were effective even if they were added immediately before entry into S phase. Inhibition of DNA synthesis was sustained when hydroxyurea, which blocks cell cycle at the G1 S border, was added after the removal of PGA2, and vice versa; PGs blocked DNA synthesis when they were added after the removal of hydroxyurea. Levels of c-myc mRNA formed two peaks during the G1 phase, at 1-2 h and at 8-12 h. The PGs did not affect the first elevation, but enhanced the second and sustained it up to 18-24 h, whereas in controls, c-myc mRNA decreased quickly after entry into S phase. The rate of degradation of c-myc mRNA was much smaller in PG-treated cells than in nontreated cells. We conclude, therefore, that PGA and PGJ inhibit a crucial event(s) in the cell cycle occurring at the G1 S border, but that this inhibition is not accompanied by the reduction in c-myc gene expression in contrast with some types of tumor cells treated With PGs.

Original languageEnglish
Pages (from-to)351-357
Number of pages7
JournalExperimental Cell Research
Volume200
Issue number2
DOIs
Publication statusPublished - Jan 1 1992
Externally publishedYes

Fingerprint

Prostaglandins A
Cell Cycle Checkpoints
Vascular Smooth Muscle
Prostaglandins
Smooth Muscle Myocytes
Hydroxyurea
S Phase
Messenger RNA
DNA
Cell Cycle
myc Genes
Eicosanoids
G1 Phase
Culture Media
Gene Expression
9-deoxy-delta-9-prostaglandin D2
Serum
prostaglandin A2
Neoplasms

All Science Journal Classification (ASJC) codes

  • Cell Biology

Cite this

Prostaglandins A and J arrest the cell cycle of cultured vascular smooth muscle cells without suppression of c-myc expression. / Sasaguri, Toshiyuki; Masuda, Junichi; Shimokado, Kentaro; Yokota, Tasuku; Kosaka, Chiya; Fujishima, Masatoshi; Ogata, Jun.

In: Experimental Cell Research, Vol. 200, No. 2, 01.01.1992, p. 351-357.

Research output: Contribution to journalArticle

Sasaguri, Toshiyuki ; Masuda, Junichi ; Shimokado, Kentaro ; Yokota, Tasuku ; Kosaka, Chiya ; Fujishima, Masatoshi ; Ogata, Jun. / Prostaglandins A and J arrest the cell cycle of cultured vascular smooth muscle cells without suppression of c-myc expression. In: Experimental Cell Research. 1992 ; Vol. 200, No. 2. pp. 351-357.
@article{1a82078ebcf6463098308125c4c019a9,
title = "Prostaglandins A and J arrest the cell cycle of cultured vascular smooth muscle cells without suppression of c-myc expression",
abstract = "The effects of prostaglandins (PGs) A and J, which are antitumor eicosanoids, on the proliferation of cultured vascular smooth muscle cells were investigated. Serum-stimulated DNA synthesis was potently inhibited by PGA1, PGA2, PGJ2, and δ12-PGJ2 in similar dose-dependent fashions. The effects of PGA1 and PGA2 were reversible when they were removed from the culture media, whereas recoveries were only partial in the cells treated with PGJ2 and δ12-PGJ2. PGs were effective even if they were added immediately before entry into S phase. Inhibition of DNA synthesis was sustained when hydroxyurea, which blocks cell cycle at the G1 S border, was added after the removal of PGA2, and vice versa; PGs blocked DNA synthesis when they were added after the removal of hydroxyurea. Levels of c-myc mRNA formed two peaks during the G1 phase, at 1-2 h and at 8-12 h. The PGs did not affect the first elevation, but enhanced the second and sustained it up to 18-24 h, whereas in controls, c-myc mRNA decreased quickly after entry into S phase. The rate of degradation of c-myc mRNA was much smaller in PG-treated cells than in nontreated cells. We conclude, therefore, that PGA and PGJ inhibit a crucial event(s) in the cell cycle occurring at the G1 S border, but that this inhibition is not accompanied by the reduction in c-myc gene expression in contrast with some types of tumor cells treated With PGs.",
author = "Toshiyuki Sasaguri and Junichi Masuda and Kentaro Shimokado and Tasuku Yokota and Chiya Kosaka and Masatoshi Fujishima and Jun Ogata",
year = "1992",
month = "1",
day = "1",
doi = "10.1016/0014-4827(92)90182-8",
language = "English",
volume = "200",
pages = "351--357",
journal = "Experimental Cell Research",
issn = "0014-4827",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Prostaglandins A and J arrest the cell cycle of cultured vascular smooth muscle cells without suppression of c-myc expression

AU - Sasaguri, Toshiyuki

AU - Masuda, Junichi

AU - Shimokado, Kentaro

AU - Yokota, Tasuku

AU - Kosaka, Chiya

AU - Fujishima, Masatoshi

AU - Ogata, Jun

PY - 1992/1/1

Y1 - 1992/1/1

N2 - The effects of prostaglandins (PGs) A and J, which are antitumor eicosanoids, on the proliferation of cultured vascular smooth muscle cells were investigated. Serum-stimulated DNA synthesis was potently inhibited by PGA1, PGA2, PGJ2, and δ12-PGJ2 in similar dose-dependent fashions. The effects of PGA1 and PGA2 were reversible when they were removed from the culture media, whereas recoveries were only partial in the cells treated with PGJ2 and δ12-PGJ2. PGs were effective even if they were added immediately before entry into S phase. Inhibition of DNA synthesis was sustained when hydroxyurea, which blocks cell cycle at the G1 S border, was added after the removal of PGA2, and vice versa; PGs blocked DNA synthesis when they were added after the removal of hydroxyurea. Levels of c-myc mRNA formed two peaks during the G1 phase, at 1-2 h and at 8-12 h. The PGs did not affect the first elevation, but enhanced the second and sustained it up to 18-24 h, whereas in controls, c-myc mRNA decreased quickly after entry into S phase. The rate of degradation of c-myc mRNA was much smaller in PG-treated cells than in nontreated cells. We conclude, therefore, that PGA and PGJ inhibit a crucial event(s) in the cell cycle occurring at the G1 S border, but that this inhibition is not accompanied by the reduction in c-myc gene expression in contrast with some types of tumor cells treated With PGs.

AB - The effects of prostaglandins (PGs) A and J, which are antitumor eicosanoids, on the proliferation of cultured vascular smooth muscle cells were investigated. Serum-stimulated DNA synthesis was potently inhibited by PGA1, PGA2, PGJ2, and δ12-PGJ2 in similar dose-dependent fashions. The effects of PGA1 and PGA2 were reversible when they were removed from the culture media, whereas recoveries were only partial in the cells treated with PGJ2 and δ12-PGJ2. PGs were effective even if they were added immediately before entry into S phase. Inhibition of DNA synthesis was sustained when hydroxyurea, which blocks cell cycle at the G1 S border, was added after the removal of PGA2, and vice versa; PGs blocked DNA synthesis when they were added after the removal of hydroxyurea. Levels of c-myc mRNA formed two peaks during the G1 phase, at 1-2 h and at 8-12 h. The PGs did not affect the first elevation, but enhanced the second and sustained it up to 18-24 h, whereas in controls, c-myc mRNA decreased quickly after entry into S phase. The rate of degradation of c-myc mRNA was much smaller in PG-treated cells than in nontreated cells. We conclude, therefore, that PGA and PGJ inhibit a crucial event(s) in the cell cycle occurring at the G1 S border, but that this inhibition is not accompanied by the reduction in c-myc gene expression in contrast with some types of tumor cells treated With PGs.

UR - http://www.scopus.com/inward/record.url?scp=0026741812&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026741812&partnerID=8YFLogxK

U2 - 10.1016/0014-4827(92)90182-8

DO - 10.1016/0014-4827(92)90182-8

M3 - Article

VL - 200

SP - 351

EP - 357

JO - Experimental Cell Research

JF - Experimental Cell Research

SN - 0014-4827

IS - 2

ER -